Latest News and Press Releases
Want to stay updated on the latest news?
-
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February
-
Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy
-
Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference